Emerging data suggest this peptide, a dual stimulator targeting both GLP-1 and glucose-dependent insulinotropic polypeptide , appears to offer a promising step forward for obesity treatment. Early human https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026